Established more than a century ago, Kewaunee Scientific Corporation is headquartered in Statesville, North Carolina. This globally recognized leader operates in the market of providing high-quality laboratory infrastructure solutions, including laboratory furniture, fume hoods and enclosures, flexible systems, cartel solutions, and accessories.
The corporation has been publicly traded since 1969 and is listed on the NASDAQ Global Market under the ticker symbol KEQU. The fact that it has been a listed company for so many decades attests to Kewaunee's stability, longevity, and successful operations.
Kewaunee Scientific Corporation serves a diverse range of customers in the pharmaceutical, healthcare, education, and industrial sectors, as well as government institutions. With a keen focus on understanding the unique requirements of each client, Kewaunee offers bespoke solutions that cater to specific needs. Its laboratories are designed to facilitate research and innovation, providing a safe, efficient, and stimulating work environment.
Kewaunee's operations are international, with manufacturing facilities and offices in the United States, India, Singapore, and China. With this global footprint, the corporation has the capability to serve customers in more than 50 countries around the world. Kewaunee's global outreach has enabled it to diversify its customer base and mitigate the geographical risks associated with relying on a single marketplace.
The corporation's focus on R&D and innovation is noteworthy. Kewaunee has committed to consistently integrating cutting-edge technologies into its operations and offerings. This commitment enables Kewaunee to continually provide state-of-the-art laboratory solutions, emphasizing safety, user-friendliness, and environmental sustainability. Furthermore, its commitment to environmental responsibility is evident in the sustainable design practices in its products.
Despite being a century-old corporation, Kewaunee continues to evolve and adapt to changing market dynamics. An important part of its strategy is continual investment in new product development, improving internal processes, optimizing resources, and enhancing customer satisfaction.
Their mission is to provide advanced lab environments that will make a paradigm shift in how research spaces are perceived and utilized. The corporation's commitment towards nurturing an ethos of innovation, quality, safety, and sustainability has secured Kewaunee's place as a trusted leader in the laboratory infrastructure solutions industry. This track record offers a solid foundation for continued growth in the decades to come.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Kewaunee Scientific Corporation (KEQU) has agreed to acquire NYCOM, Inc. for an initial base price of $55 million, with $30 million payable in cash at closing, $20 million via a subordinated seller note, and $5 million in Kewaunee common shares. The acquisition, expected to close in the fourth quarter of fiscal 2027, aims to integrate NYCOM's laboratory design and project delivery expertise with Kewaunee's manufacturing capabilities to offer comprehensive laboratory solutions. The deal also includes provisions for adjusted EBITDA-based adjustments and potential termination conditions.
This article provides an in-depth analysis of Kewaunee Scientific Corporation (NASDAQ: KEQU) movements, highlighting a potential shift in near-term sentiment and a broader weak alignment. It identifies an exceptional 25.8:1 risk-reward short setup and outlines three distinct AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) with detailed entry, target, and stop-loss zones. The analysis also includes a multi-timeframe signal breakdown for near-term, mid-term, and long-term horizons, providing crucial support and resistance levels.
This article analyzes Kewaunee Scientific Corporation (NASDAQ: KEQU), indicating a near-term neutral sentiment suggesting a pause in mid and long-term weakness. It highlights an exceptional 30.3:1 risk-reward setup targeting an 8.4% gain versus 0.3% risk. The report also details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis.
Kewaunee Scientific (NASDAQ:KEQU) briefly traded above its 200-day moving average of $36.91 before closing at $35.55 on low volume. Analyst sentiment for the stock remains cautious, with both Weiss Ratings and MarketBeat's tracked analyst issuing "Hold" ratings. The company recently reported quarterly EPS of $0.58 on revenue of $66.32 million, and institutional investors currently hold 32.69% of its shares.
Kewaunee Scientific (NASDAQ: KEQU) rebranded its Domestic reportable segment as Lab Products Group in fiscal year 2026, coinciding with a significant backlog of $169.0 million. While the rebranding reflects expanded activities, it did not impact previously disclosed financial data. The company reported a 6.7% decrease in first-quarter sales to $66.32 million and a drop in diluted EPS to $0.58, though its international segment saw net earnings rise by 23.5%.
Kewaunee Scientific Corporation reported a decline in Q1 fiscal 2027 earnings and sales year-over-year, with sales falling 6.7% to $66.3 million and EPS decreasing to 58 cents from $1.04. Despite overall declines, the International segment saw an increase in net earnings and EBITDA due to a favorable mix of higher-margin projects. Management noted strong quoting activity indicating underlying demand, but project timelines remain extended due to geopolitical and economic uncertainties.